Skip to content
Search

Latest Stories

Follow Us:
Top Stories

The Health Care Debate & Feldstein’s Fix

Opinion

The Health Care Debate & Feldstein’s Fix
black and gray stethoscope

Serving in Congress during the implementation of President Barack Obama’s Affordable Care Act, Republicans embraced the position of “repeal and replace.” Repeal the ACA, but replace it with what? The debate is front-and-center again, though the ground has shifted some. There is more support for the ACA. Even some Republicans are looking to temporarily extend COVID-era subsidies for ACA health plans. Other Republicans want Health Savings Accounts, so more money goes to individuals instead of insurance companies. Democratic leadership seeks an approach temporarily extending the expanded premium subsidies, during which the entire approach to health care can be rethought.

The late economist Martin Feldstein had the fix: Martin Feldstein proposed a voucher system in which everyone could purchase a health insurance plan covering health care expenses exceeding 15% of their income. This could be combined with HSAs if they prove popular with the public.


The variable prices for medical care across common geographic areas help illustrate that greater cost-consciousness in health care could have an impact. “In a well-functioning competitive market, prices for the same service will not vary widely within a given place,” the Brookings Institute summed it up. Brookings offers two examples: “Estimates from the Health Care Cost Institute show that the price for a blood test ranges from $22 (10th percentile) to $37 (90th percentile) in Baltimore, Maryland, but in El Paso, Texas, the same range is $144 to $952. For a C-section delivery, prices vary widely both across and within markets: the 10th to 90th percentile range is 9.3 times larger in the San Francisco, California, metro area than in the Knoxville, Tennessee, metropolitan area. Getting a well-functioning competitive marketplace will drive prices down while still incentivizing quality care.

So, rethinking the health care system has value, but any debate should also consider whether a little more free-market would be beneficial in our mixed-economy health care system. The advantage of the Feldstein proposal rests here: There would be greater price sensitivity in the health care sector, a sensitivity that encourages greater efficiency and cost-lowering, competitive innovation.

Physicians, hospitals, and other health care facilities would gain reputations as being more expensive or less expensive. A doctor might be willing to provide discounts to patients in need, especially if we also generously fund non-profit community health centers for the medically needy. There may be more conversations about the frequency of checkups or the duration of a long-term stay. Fewer tests that are not truly necessary. Lower administrative expenses. Less headaches with insurance in general.

If someone buys insurance to work in conjunction with Feldstein’s proposal, premiums would be lower due to several factors. The insurance policy would not have to cover as much. There would be greater predictability for each insurer about how much risk they are taking on with any one policyholder, and that predictability would encourage more competition within the consumer insurance market.

There was an interim version of the Affordable Care Act from 2014 to 2016, as the bill’s health insurance exchanges were coming into being. Specifically, the Transitional Reinsurance Program in the ACA was a government-provided reinsurance policy that supported insurance plans in the individual market by covering a portion of a plan’s costs, starting in 2014 at 100% of costs between $45,000 and $250,000. The cost of doing so was financed through a fee on plans in both the individual and group marketplaces. Something which reduced health insurance premiums for the individual market by 10-14%. That is the real-world experience of the benefit of reducing risk to any one insurance plan.

Income-related cost sharing, as proposed by Feldstein, could reduce health premiums even further. By one estimate, a whopping 22-34% of overall health expenses. All without jeopardizing patient care.

Feldstein’s article and its ideas never became a significant part of the health care debate. Six months after the publication of the Feldstein proposal, the Affordable Care Act was signed into law by President Obama. After the transition period, the bill created only a complicated set of taxes and subsidies, a kind of Rube Goldberg device – different pieces creating incentives for different directions, not certain to come together in the best way for the American people. The complexity of today's health care system under ACA continues to collide with the complexity of how we pay - or sometimes don't pay - for it. We should have a health care system as good as our current system, and then some. A health care system that can heal itself with the right incentives. All of which means not becoming Canada or Great Britain with their longer wait times; rather, creating a unique American system along the lines of the Feldstein model.

A couple more years of debate over health care could perhaps lead to this bolder approach if part of the political culture embraces it. Even if not, debate over cost-consciousness must occur. Taking care of the sick is a moral imperative for government; red tape, bureaucracy, high health care costs, and narrow provider networks are not.

Scott Miller is a graduate of Widener School of Law, a former chief of staff in Congress, and the author of 'Christianity & Your Neighbor's Liberty.


Read More

FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.

The FDA’s changing drug approval policies raise concerns about political influence, scientific standards, drug safety, and the future of U.S. pharmaceutical regulation.

JHVEPhoto/Getty Images

FDA Turmoil: Political Interference Threatens Drug Safety Standards

Over the past three decades, drug development in the United States accelerated dramatically. Industry spending increased tenfold between the 1980s and 2019; the number of manufacturers grew; clinical trials became more sophisticated; and new technologies and precision medicines emerged. The Food and Drug Administration kept pace, building processes, standards, and a scientific culture that supported this rapid innovation. It offered pharmaceutical companies a predictable regulatory environment and a level playing field, producing substantial benefits for consumers and researchers alike.

In little more than a year, however, the Trump administration has upended many of these FDA norms. It has tied certain drug approvals to political considerations through a new, opaque program; imposed labeling changes without new scientific evidence; forced out experienced career scientists; replaced respected experts on advisory panels; and promoted unproven therapies. While some of these moves have drawn limited media attention, most have escaped public notice—even though they threaten national health standards and consumer safety. And legal guardrails may be too weak to prevent or limit their effects.

Keep ReadingShow less
A Senior Man Using A Laptop Computer And Paying Bills With Nurse

H.R. 1 could leave millions uninsured, increase healthcare costs, strain hospitals, and affect even Americans with employer-sponsored health insurance.

miniseries/Getty Images

Not All Change Is Good: Medicaid, Medicare Shifts Are Everyone’s Problem

Like 155 million other Americans, I get my health insurance coverage through my employer. The millions like me who are not on Medicaid or Medicare may not be closely tracking the massive changes coming to public insurance programs because of H.R.1 (also known as President Donald Trump’s “One Big Beautiful Bill Act”).

But over the next decade, it’s estimated that up to 10 million people may lose health insurance because of changes to Medicare and Medicaid.

Keep ReadingShow less
The All-America City of San Antonio Collaborates to Address Teen Pregnancy and Other Issues
person in green pants sitting on white textile
Photo by Vanessa on Unsplash

The All-America City of San Antonio Collaborates to Address Teen Pregnancy and Other Issues

San Antonio, TX, has been working to reduce teen pregnancy for over two decades, making considerable progress through collaborations among the city, county, nonprofit organizations, and the University of Texas. A nine-time All-America City, one of San Antonio’s key community collaborations, SA 2020, harnessed civic muscle to create and achieve dozens of measurable goals, including a significant reduction in teen pregnancy.

The San Antonio Teen Pregnancy Collaborative (SATPPC) was formed in 2010 in response to news that Bexar County had one of the highest rates of teen births in the United States. The SATPPC brought together an impressive list of cross-sector organizations, including public entities, community-based organizations, and faith-based and secular institutions. The group’s overall goal was to reduce the Bexar County teen birth rate among females ages 15 to 19 by 15% by 2020, and it exceeded this goal even before that date.

Keep ReadingShow less
In Milwaukee, J.D. Vance Ties Trump's Fraud Task Force to Medicaid and SNAP Crackdowns

U.S. Vice President JD Vance speaks at the 128th Air Refueling Wing Hangar on July 08, 2026, in Milwaukee, Wisconsin. Vance traveled to Milwaukee to deliver remarks on the Trump administration's anti-fraud initiatives.

(Photo by Scott Olson/Getty Images)

In Milwaukee, J.D. Vance Ties Trump's Fraud Task Force to Medicaid and SNAP Crackdowns

MILWAUKEE, Wisconsin– Vice President J.D. Vance visited Milwaukee on July 8 to promote the Trump administration’s crackdown on fraud at the state and federal levels in programs like Medicare and SNAP.

Speaking inside an aircraft hangar at the Wisconsin Air National Guard’s 128th Air Refueling Wing, in front of a banner reading “Protect Taxpayer Dollars,” Vance cast the anti‑fraud efforts to protect both taxpayers and the programs themselves.

Keep ReadingShow less